23 Jul, EOD - Indian

SENSEX 80429.04 (-0.09)

Nifty 50 24479.05 (-0.12)

Nifty Bank 51778.3 (-0.96)

Nifty IT 40044.7 (0.68)

Nifty Midcap 100 56285.25 (-0.60)

Nifty Next 50 71632.2 (-0.88)

Nifty Pharma 20755.35 (0.55)

Nifty Smallcap 100 18400.5 (-0.88)

23 Jul, EOD - Global

NIKKEI 225 39508.84 (-0.22)

HANG SENG 17369.41 (-0.57)

DOW JONES 40358.09 (-0.14)

S&P 5555.74 (-0.16)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(14 Jun 2024, 11:06)

Cupid rises after bagging contract manufacturing deal from Cipla Health

Cupid added 1.06% to Rs 95.92 after the company announced that it has received an initial order from Cipla Health to manufacture a range of male condoms under the 'Cipla’ brand.


Following this initial rollout, Cipla Health has committed to placing regular, sizeable orders for male condoms with Cupid Limited in the coming quarters.

Swapnil Dhage, marketing manager at Cupid, said: "We have had productive discussions with the Cipla Health team and are excited about this long-term and mutually beneficial partnership. Securing this initial order is a significant milestone for us, and we look forward to growing our business with Cipla Health.

Cupid is dedicated to manufacturing top-quality products, whether under our brand or for established players and new market entrants. We are enthusiastic about taking on all opportunities to deliver excellence."

Cupid is India's premier manufacturer of male and female condoms, water-based lubricant jelly, and IVD kit...

More News
More Company News View Company Information